Status:
UNKNOWN
HEART Rate Variability Biofeedback in LOng COVID-19 (HEARTLOC)
Lead Sponsor:
University of Leeds
Collaborating Sponsors:
University of Manchester
Leeds Comunity Healthcare NHS Trust
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Long COVID is a common but highly debilitating illness which develops after infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 or COVID-19). It is thought to affect as many as ...
Detailed Description
Participants will be shown a paced breathing programme and instructed to implement this for 10 minutes twice daily for 4 weeks. During the 10 minute breathing exercises, the participant will need to w...
Eligibility Criteria
Inclusion
- Age \> 18 years
- Confirmed Long COVID based on a positive PCR or antibody test and Long COVID symptoms as per the NICE criteria for post-COVID syndrome
- Current Leeds COVID Rehabilitation service user
- Self-rating of 'moderate/severe' on the Leeds COVID Rehabilitation Service Long COVID participant reported outcome measure (known as C19-YRS)
- Abnormal NASA Lean Test (NLT)
Exclusion
- Age \< 18 years
- Unable to use the wearable or smartphone app technology
- Cognitive problems or mental health disorders causing inability to consent
- Cardiac arrhythmia (current or prior tachyarrhythmia or bradyarrhythmia)
- Existing significant cardiorespiratory disease which might be expected to affect studied symptoms of palpitations, presyncope, breathlessness and fatigue (asthma not included in this definition)
Key Trial Info
Start Date :
January 24 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2024
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05228665
Start Date
January 24 2022
End Date
March 31 2024
Last Update
October 24 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Leeds Community Healthcare NHS Trust
Leeds, Yorkshire, United Kingdom, LS12 5SG